Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: History and rationale

Charles Ryan, Amy M. Lin, Eric J. Small

Research output: Contribution to journalReview articlepeer-review

30 Scopus citations

Fingerprint Dive into the research topics of 'Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: History and rationale'. Together they form a unique fingerprint.

Medicine & Life Sciences